Managing Insulin With a Voice AI

Stanford University39 enrolled

Overview

This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Medication Adherence

Interventions

Voice Assistant DeviceDEVICE

Voice AI-enabled smart speaker device delivers daily custom insulin titration instructions.

Voice Assistant DeviceDEVICE

Voice AI-enabled smart speaker device delivers daily generic insulin reminders.

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Type 2 Diabetes * Patients clinically indicated to be taking daily long-acting insulin * Patients currently taking long-acting insulin but necessitating active dose adjustments Exclusion Criteria: * Patients who do not speak English * Patients who do not own a smart phone * Patients who do not have stable wireless internet connection at home

Locations (1)

Stanford University

Stanford, California, United States

Outcomes

Primary Outcomes

Time to Optimal Insulin Dose

Number of days between study start date and goal fasting sugar

Time frame: 8 weeks

Insulin Medication Adherence

Percentage of adherence to taking insulin based on logs over 8 weeks

Time frame: 8 weeks

Attitudes Toward Diabetes

Change in Composite Score of Attitudes Toward Diabetes (PAID-5). A 5-item psychometrically validated self-report questionnaire on a 5 point Likert scale (0= not problem; 4= a serious problem). The scores of each item are summed to create an overall score (Minimum value = 0; Maximum value = 20). Higher scores denote higher levels of diabetes related distress.

Time frame: Baseline and 8 weeks

Attitudes Toward Health Technology

Change in Composite Score of Attitudes Toward Health Technology. A 2-item self-report questionnaire on a 5 point Likert scale, scored 0 to 4. The scores are summed to create an overall score (Minimum value = 0, Maximum value = 8). Higher scores indicated more favorable attitudes toward health technology.

Time frame: Baseline and 8 weeks

Attitudes Toward Medication Adherence

Change in Composite Score of Attitudes Toward Medication Adherence. A 5-item self-report questionnaire on a 5-point Likert scale (0 to 4). The scores are summed to create an overall score (Minimum value = 0, Maximum value = 20). Higher scores indicate more favorable attitudes toward medication adherence.

Time frame: Baseline and 8 weeks

Secondary Outcomes

Percentage of Participants Who Achieved Glycemic Control

Proportion (percentage) of participants with fasting sugar within goal at end of trial.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.